We used a thioacetamide (TAA)-induced intrahepatic cholangiocarcinoma (iCCA) rat model to investigate the DNA vaccine potential against CTLA4, PD-1, and PD-L1. The gene discussed is PDCD1; the disease is intrahepatic cholangiocarcinoma.